MariMed Inc.
MRMD
$0.07
$0.000.14%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.16% | 6.93% | 0.42% | -2.05% | -0.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.16% | 6.93% | 0.42% | -2.05% | -0.07% |
| Cost of Revenue | 6.08% | 18.46% | 2.47% | 0.21% | 6.32% |
| Gross Profit | 1.24% | -17.02% | -2.50% | -5.19% | -8.40% |
| SG&A Expenses | -5.70% | 6.86% | -2.97% | -5.45% | 10.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.25% | 14.44% | 0.36% | -2.05% | 8.03% |
| Operating Income | 136.84% | -235.48% | 1.63% | -1.99% | -137.91% |
| Income Before Tax | 57.85% | -120.99% | 45.67% | 25.10% | -765.33% |
| Income Tax Expenses | -6.36% | -154.30% | 321.22% | -20.21% | 67.51% |
| Earnings from Continuing Operations | 31.25% | 43.84% | -197.07% | 22.51% | -324.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 43.75% | 433.33% | 56.25% | 108.33% | -433.33% |
| Net Income | 31.32% | 43.98% | -193.04% | 23.14% | -324.58% |
| EBIT | 136.84% | -235.48% | 1.63% | -1.99% | -137.91% |
| EBITDA | 62.48% | -190.19% | 3.00% | 5.82% | -48.47% |
| EPS Basic | 34.03% | 46.08% | -188.46% | 25.00% | -311.43% |
| Normalized Basic EPS | 38.10% | -101.92% | -- | 0.00% | -520.00% |
| EPS Diluted | 30.56% | 46.08% | -284.62% | 25.00% | -311.43% |
| Normalized Diluted EPS | 38.10% | -101.92% | -- | 0.00% | -520.00% |
| Average Basic Shares Outstanding | 3.89% | 3.69% | 3.16% | 2.74% | 1.96% |
| Average Diluted Shares Outstanding | 3.89% | 3.69% | 3.16% | 2.74% | 1.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |